Reassessing the safety of intravenous and compounded injectable colchicine in acute gout treatment

Bibliography

• WEEDE RP: Poison in the Pot. The Legacy of Lead Southern Illinois University Press: Carbondale and Edwardsville (1984):83.
   Google Scholar
• SINGER C: A History of Scientific Ideas Barnes and Nobles (1996).
   Google Scholar
• PELLETIER PS, CAVENTON J: Ann. Chim. Phys. (1820) 14:69.
   Google Scholar
• CORRODI H, HARDEGGER E: Die Konfiguration des Colchicins und verwandter Verbindungen. Helv. Chem. Acta (1955) 38:2030-2033.
   Web of Science ®Google Scholar
• AHERN MJ, REID C, GORDON TP: Does colchicine work? Results of the first controlled study in gout. Aust. NZ J. Med. (1987) 17:301-304.
   PubMedGoogle Scholar
• PAULUS HE, SCHLOSSTEIN LH, GODFREY RC, KLINENBERG JR, BLUESTONE R: Prophylactic colchicine therapy in intercritical gout. Arthritis Rheum. (1987) 17:609-614.
   Web of Science ®Google Scholar
• SCHLESINGER N, SCHUMACHER HR Jr, CATTON M, MAXWELL L: Colchicine therapy for acute gout. Review: cochrane international collaboration. Cochrane Database Syst. Rev. (2006) 18(4):CD006190.
   Google Scholar
• KATZUNG BG: In: Basic and Clinical Pharmacology. Katzung BG (Ed.), Apleton and Lange, Norwalk, CT, USA (1995):536-559.
   Google Scholar
• SCHUMACHER H, KLIPPEL J, KOOPMAN W: In: Primer on the Rheumatic Diseases. (10th Edition). (Ed.), Arthritis Foundation (1993).
   Google Scholar
• SCHLESINGER N: Management of acute and chronic gouty arthritis: present state-of-the-art. Drugs (2004) 64(21):2399-2416.
   PubMed Web of Science ®Google Scholar
• LEVY M, SPINO M, READ SE: Colchicine: a state-of-the-art review. Pharmacotherapy (1991) 11:196-211.
   PubMed Web of Science ®Google Scholar
• BEN-CHETRIT E, SCHERRMANN JM, ZYLBER-KATZ E, LEVY M: Colchicine disposition in patients with Mediterranean fever with renal impairment. J. Rheumatol. (1991) 18:264-269.
   PubMed Web of Science ®Google Scholar
• TATEISHI T, SOUCEK P, CARACO Y, GUENGERICH P, WOODS AJJ: Colchicine biotransformation by human liver microsomes. Biochem. Pharmacol. (1997) 53:111-116.
   PubMed Web of Science ®Google Scholar
• SPEEG KV, MALDONADO AL, LIACI J, MUIRHEAD D: Effect of cyclosporine on colchicine secretion by a liver canalicular transporter studied in vivo. Hepatology (1992) 15:899-903.
   PubMed Web of Science ®Google Scholar
• FERRON GM, ROCHDI M, JUSKO WJ, SCHERRMANN JM: Oral absorption characteristics and pharmacokinetics of colchicine in healthy volunteers after single and multiple doses. J. Clin. Pharmacol. (1996) 36:874-883.
   PubMed Web of Science ®Google Scholar
• ERTEL NH, MITTLER JC, AKGUN S, WALLACE SL: Radioimmunoassay for colchicine in plasma and urine. Science (1976) 193:233-235.
   PubMed Web of Science ®Google Scholar
• HUNG IFN, WU AKL, CHENG VCC et al.: Fatal interaction between clarithromycin and colchicine in patients with renal insufficiency: a retrospective study. Clin. Infect. Dis. (2005) 41:291-300.
   PubMed Web of Science ®Google Scholar
• PUTTERMAN C, BEN-CHETRIT E, CARACO Y, LEVY M: Colchicine intoxication: clinical pharmacology, risk factors, features and management. Semin. Arthritis Rheum. (1991) 21:143-155.
   PubMed Web of Science ®Google Scholar
• SUSSMA JS, BROZENA SC, SKOP N, KORECKA M, SHAW LM: Accidental intravenous colchicine poisoning. Ther. Drug Monit. (2004) 26(6):688-692.
   PubMed Web of Science ®Google Scholar
• SAUDER P, KOPFERSCHMITT J, JAEGER A, MANTZ JM: Haemodynamic studies in eight cases of acute colchicine poisoning. Hum. Toxicol. (1983) 2:169-173.
   PubMedGoogle Scholar
• LUCIANI I: Fatal IV colchicine injection in a 60-year old woman. J. Emerging Nurs. (1989) 15:80-82.
   PubMedGoogle Scholar
• ROBERTS WN, LIANG MH, STERN SH: Colchicine in acute gout: reassessment of risks and benefits. JAMA (1987) 257:1920-1922.
   PubMed Web of Science ®Google Scholar
• DAVIS JS, BARTFIELD H: The effect of intravenous colchicine on acute gout. Am. J. Med. (1954) 16:218-219.
   PubMed Web of Science ®Google Scholar
• WALLACE SL, BERNSTEIN D, DIAMOND H: Diagnostic value of colchicine theraouetic trial. JAMA (1967) 199:93-96.
   PubMed Web of Science ®Google Scholar
• HAWKINS DW, RAHN DW: Gout and hyperuricemia. In: Pharmacotherapy: A Pathophysiologic Approach. (5th Edition), Dipiro JT, Talbert RL, Yee GC et al. (Eds), McGraw-Hill, New York, USA (2002):1659-1664.
   Google Scholar
• WALSH CS, GRISSINGER M: Medication errors: prevention guidelines. Pharm. Pract. News (2002):39-41. ISMP.
   Google Scholar
• WALLACE SL, SINGER JZ: Review: systemic toxicity associated with the intravenous administration of colchicines – guidelines for use. J. Rheumatol. (1988) 15:495-499.
   PubMed Web of Science ®Google Scholar
• MALDONADO MA, SALZMAN A, VARGA J: Intravenous colchicine use in crystal-induced arthropathies: a retrospective analysis of hospitalized patients. Clin. Exp. Rheumatol. (1997) 15(5):487-492.
   PubMed Web of Science ®Google Scholar
• EVANS IT, WHEELER MT, SMALL RE, BREITBACH SA, SANDERS KM, ROBERTS WN: A comprehensive investigation of inpatient colchicine use shows more education is needed. J. Rheumatol. (1996) 23:143.
   PubMed Web of Science ®Google Scholar
• MULLINS ME, CARRICO EA, HOROWITZ Z: Fatal cardiovascular collapse following acute colchicine ingestion. Clin. Toxicol. (2000) 38:51-54.
   Web of Science ®Google Scholar
• PAWLOTSKY Y: What is the optimal treatment for acute crystal-induced arthritis? Rev. Rhum. (Engl. Ed.) (1996) 63(4):231-233.
   PubMedGoogle Scholar
• RASK MR: Colchicine use in 6000 patients with disk disease & other related resistantly-painful spinal disorders. J. Neurol. Orthop. Med. Surg. (1989) 10:291-298.
   Google Scholar